# A Study to Determine the Safety and Efficacy of Bevacizumab Administered Via Injection Into the Shoulder Joint of Participants With Adhesive Capsulitis (Frozen Shoulder)

> **NCT06976671** · PHASE2 · RECRUITING · sponsor: **Macquarie University, Australia** · enrollment: 28 (estimated)

## Conditions studied

- Adhesive Capsulitis

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT06976671
- **Lead sponsor:** Macquarie University, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-10
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06976671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06976671, "A Study to Determine the Safety and Efficacy of Bevacizumab Administered Via Injection Into the Shoulder Joint of Participants With Adhesive Capsulitis (Frozen Shoulder)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06976671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*